BTTP is the latest generation of accelerating ligands for CuAAC, which provides greater rate enhancement compared to previous generation ligands such as THPTA or TBTA. More importantly, it minimizes disturbance to the physiological state of the probed cells or organisms, and enables efficient bioconjugation and inhibition of cytotoxicity by further reducing the copper loading in the catalyst formulation.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
